Clinical Trial Update: Avoiding Treatment in the Hospital With Furoscix for the Management of Congestion in Heart Failure - A Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating furoscix for avoiding hospitalization in heart failure patients with congestion has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• FUROSCIX (Furosemide injection 80 mg/10 mL)

Snippet

Sponsor: scPharmaceuticals, Inc. | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2023-08-01